.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

VASERETIC Drug Profile

« Back to Dashboard

Which patents cover Vaseretic, and what substitute generic drugs are available?

Vaseretic is a drug marketed by Valeant Intl and is included in one NDA.

The generic ingredient in VASERETIC is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.

Summary for Tradename: VASERETIC

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list77
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VASERETIC at DailyMed

Pharmacology for Tradename: VASERETIC

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-003Jul 12, 1995RXYesNo► Subscribe► Subscribe
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-001Oct 31, 1986RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VASERETIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-003Jul 12, 19954,374,829*PED► Subscribe
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-003Jul 12, 19954,472,380*PED► Subscribe
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-001Oct 31, 19864,472,380*PED► Subscribe
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-001Oct 31, 19864,374,829*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc